CWP232228 targets liver cancer stem cells through Wnt/beta-catenin signaling: a novel therapeutic approach for liver cancer treatment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ji-Young | - |
dc.contributor.author | Lee, Hwa-Yong | - |
dc.contributor.author | Park, Kwan-Kyu | - |
dc.contributor.author | Choi, Yang-Kyu | - |
dc.contributor.author | Nam, Jeong-Seok | - |
dc.contributor.author | Hong, In-Sun | - |
dc.date.available | 2020-02-28T02:42:26Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2016-04-12 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8382 | - |
dc.description.abstract | Liver cancer stem cells (CSCs) are resistant to conventional chemotherapy and radiation, which may destroy tumor masses, but not all liver CSCs contribute to tumor initiation, metastasis, and relapse. In the present study, we showed that liver CSCs with elevated Wnt/beta-catenin signaling possess much greater self-renewal and clonogenic potential. We further documented that the increased clonogenic potential of liver CSCs is highly associated with changes in Wnt/beta-catenin signaling and that Wnt/beta-catenin signaling activity is positively correlated with CD133 expression and aldehyde dehydrogenase (ALDH) enzymatic activity. Notably, the small molecule inhibitor CWP232228, which antagonizes the binding of beta-catenin to TCF in the nucleus, inhibits Wnt/beta-catenin signaling and depletes CD133(+)/ALDH(+) liver CSCs, thus ultimately diminishing the self-renewal capacity of CSCs and decreasing tumorigenicity in vitro and in vivo. Taken together, our findings suggest that CWP232228 acts as a candidate therapeutic agent for liver cancer by preferentially targeting liver CSCs. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | IMPACT JOURNALS LLC | - |
dc.relation.isPartOf | ONCOTARGET | - |
dc.subject | HEPATOCELLULAR-CARCINOMA CELLS | - |
dc.subject | BETA-CATENIN | - |
dc.subject | PATHWAY | - |
dc.subject | EXPRESSION | - |
dc.subject | IDENTIFICATION | - |
dc.subject | ACTIVATION | - |
dc.subject | GROWTH | - |
dc.subject | CD133 | - |
dc.subject | INHIBITION | - |
dc.subject | MOUSE | - |
dc.title | CWP232228 targets liver cancer stem cells through Wnt/beta-catenin signaling: a novel therapeutic approach for liver cancer treatment | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000375804000099 | - |
dc.identifier.doi | 10.18632/oncotarget.7954 | - |
dc.identifier.bibliographicCitation | ONCOTARGET, v.7, no.15, pp.20395 - 20409 | - |
dc.identifier.scopusid | 2-s2.0-84964778097 | - |
dc.citation.endPage | 20409 | - |
dc.citation.startPage | 20395 | - |
dc.citation.title | ONCOTARGET | - |
dc.citation.volume | 7 | - |
dc.citation.number | 15 | - |
dc.contributor.affiliatedAuthor | Kim, Ji-Young | - |
dc.contributor.affiliatedAuthor | Hong, In-Sun | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | CWP232228 | - |
dc.subject.keywordAuthor | cancer stem cells | - |
dc.subject.keywordAuthor | Wnt/beta-catenin signaling | - |
dc.subject.keywordAuthor | CD133 | - |
dc.subject.keywordAuthor | ALDH | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA CELLS | - |
dc.subject.keywordPlus | BETA-CATENIN | - |
dc.subject.keywordPlus | PATHWAY | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | CD133 | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | MOUSE | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.